분석 기기 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Analytical Instrumentation Market, valued at USD 60 billion in 2024, is poised for significant growth, with projections indicating a CAGR of 6.5% from 2025 to 2034. This upward trajectory reflects the increasing integration of advanced technologies and the escalating demand for precision and accuracy across industries. Pharmaceutical and biotechnology sectors, in particular, are driving this demand as they prioritize stringent quality control measures and compliance with regulatory standards. The expanding applications of analytical instruments in healthcare, coupled with innovations in materials science, environmental monitoring, and chemical analysis, underscore the market's versatility and importance in modern industries.

Rising interest in personalized medicine, coupled with the prevalence of chronic diseases, has spurred the adoption of sophisticated diagnostic tools. Analytical instruments are playing a pivotal role in clinical laboratories and diagnostic centers, enabling accurate and efficient testing solutions. Additionally, industries are increasingly investing in R&D to enhance product quality and sustainability, further fueling the adoption of these tools. These trends, along with the growing emphasis on eco-friendly practices, are pushing industries to integrate advanced analytical solutions into their operations.

The market is categorized by product types, including electrochemical analysis instruments, chromatography instruments, molecular analysis instruments, spectroscopy instruments, particle counters and analyzers, and others. Among these, molecular analysis instruments stand out with a projected CAGR of 6.9%, expected to reach USD 39.5 billion by 2034. This segment's growth is fueled by the increasing adoption of cutting-edge techniques in research and diagnostics, particularly in genomics and proteomics. The rising need for precision in molecular-level analysis is driving demand across various sectors, including healthcare and academic research.

By technology, the market encompasses spectroscopy, chromatography, particle analysis, polymerase chain reaction, and other methods. Spectroscopy held a significant 29.8% market share in 2024, valued at USD 17.9 billion. The widespread adoption of spectroscopic techniques is attributed to their ability to perform non-destructive analyses of chemical and molecular structures. These methods are extensively used in biotechnology, pharmaceuticals, and materials science, supporting innovations in product development and quality assurance.

In the United States, the analytical instrumentation market generated USD 21.5 billion in revenue in 2024 and is forecast to grow at a CAGR of 6.2% through 2034. This growth is primarily driven by advancements in the pharmaceutical and biotechnology industries. The adoption of advanced analytical tools for drug development, clinical trials, and biomarker research has been accelerating. Personalized medicine initiatives and the need for precise diagnostic devices are further propelling market expansion in both clinical and research domains.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancements
    • 3.2.1.2 Rising R&D spending by pharmaceutical industry & government research organizations
    • 3.2.1.3 Increasing adoption of analytical instrumentation for precision medicine applications
    • 3.2.1.4 Growing prevalence of chronic diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of instruments
    • 3.2.2.2 Lack of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2024
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Volume analysis, 2021 – 2034 (Units)
  • 3.6.1 Global
  • 3.6.2 North America
  • 3.6.3 Europe
  • 3.6.4 Asia Pacific
  • 3.6.5 Latin America
  • 3.6.6 MEA
• 3.7 Technology landscape
• 3.8 Reimbursement scenario
• 3.9 Future market trends
• 3.10 Gap analysis
• 3.11 Porter’s analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Molecular analysis instruments
• 5.3 Spectroscopy instruments
• 5.4 Chromatography instruments
• 5.5 Electrochemical analysis instruments
• 5.6 Particle counters and analyzers
• 5.7 Other products

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Spectroscopy
• 6.3 Chromatography
• 6.4 Particle analysis
• 6.5 Polymerase chain reaction
• 6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Clinical research
• 7.3 Clinical diagnostics

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical & biotechnology industry
• 8.3 Research and academic institutes
• 8.4 Diagnostic centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Poland
  • 9.3.7 Sweden
  • 9.3.8 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Thailand
  • 9.4.7 Indonesia
  • 9.4.8 Philippines
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Columbia
  • 9.5.5 Chile
  • 9.5.6 Peru
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Israel
  • 9.6.5 Turkey
  • 9.6.6 Iran

Chapter 10 Company Profiles

• 10.1 Agilent
• 10.2 Avantor
• 10.3 BIO-RAD
• 10.4 BRUKER
• 10.5 Danaher
• 10.6 Eppendorf
• 10.7 HITACHI
• 10.8 Illumina
• 10.9 Malvern Panalytical
• 10.10 Metrohm
• 10.11 METTLER TOLEDO
• 10.12 Revvity (PerkinElmer)
• 10.13 Roche
• 10.14 Sartorius
• 10.15 SHIMADZU
• 10.16 Thermo Fisher Scientific
• 10.17 Waters
• 10.18 ZEISS Group